Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.455
+0.045 (1.32%)
Mar 14, 2025, 10:41 AM EDT - Market open
Relay Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 586 | 690 | 1,357 | 1,806 | 3,318 | 3,733 | |
| Market Cap Growth | -49.19% | -49.19% | -24.86% | -45.57% | -11.11% | - | |
| Enterprise Value | -155 | -100 | 601 | 813 | 2,725 | 3,043 | |
| Last Close Price | 3.41 | 4.12 | 11.01 | 14.94 | 30.71 | 41.56 | |
| PS Ratio | 48.68 | 68.91 | 53.13 | 1307.87 | 1095.42 | 45.16 | |
| PB Ratio | 0.74 | 0.89 | 1.80 | 1.90 | 3.70 | 4.89 | |
| P/TBV Ratio | 0.89 | 0.89 | 1.81 | 1.91 | 3.71 | 4.89 | |
| EV/Sales Ratio | - | - | 23.53 | 588.46 | 899.58 | 36.82 | |
| Debt / Equity Ratio | 0.06 | 0.06 | 0.07 | 0.06 | 0.03 | 0.03 | |
| Asset Turnover | 0.01 | 0.01 | 0.03 | 0.00 | 0.00 | 0.14 | |
| Quick Ratio | 15.40 | 15.40 | 24.78 | 15.76 | 39.60 | 55.80 | |
| Current Ratio | 15.95 | 15.95 | 25.44 | 16.00 | 40.14 | 56.49 | |
| Return on Equity (ROE) | -44.15% | -44.15% | -40.18% | -31.44% | -43.81% | -9.35% | |
| Return on Assets (ROA) | -28.11% | -28.11% | -24.40% | -18.44% | -15.63% | -5.85% | |
| Return on Capital (ROIC) | -29.54% | -29.54% | -26.15% | -20.15% | -16.54% | -5.96% | |
| Earnings Yield | -58.42% | -48.97% | -25.20% | -16.08% | -10.97% | -1.40% | |
| FCF Yield | -43.44% | -36.42% | -22.43% | -13.21% | -2.35% | -2.80% | |
| Buyback Yield / Dilution | -16.55% | -16.55% | -9.22% | -17.97% | -123.22% | -1135.17% | |
| Total Shareholder Return | -16.55% | -16.55% | -9.22% | -17.97% | -123.22% | -1135.17% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.